| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.79 | 0.006 | 0.79 | Analgesic | 0.758 0.008 DBMET00052 0.696 0.014 DBMET00053 0.671 0.016 DBMET00482 | ||
| 0.749 | 0.004 | 0.749 | Psychostimulant | 0.728 0.004 DBMET00052 0.639 0.005 DBMET00053 0.619 0.005 DBMET00482 | ||
| 0.683 | 0.007 | 0.768 | Spasmolytic | 0.768 0.005 DBMET00052 0.586 0.014 DBMET00053 0.675 0.007 DBMET00482 | DBMET00052 | |
| 0.647 | 0.003 | 0.647 | 5 Hydroxytryptamine 1F antagonist | 0.405 0.005 DBMET00052 0.626 0.003 DBMET00053 0.294 0.005 DBMET00482 | ||
| 0.639 | 0.011 | 0.639 | 5 Hydroxytryptamine release stimulant | 0.513 0.025 DBMET00052 0.633 0.012 DBMET00053 0.507 0.026 DBMET00482 | ||
| 0.598 | 0.004 | 0.63 | 5 Hydroxytryptamine 7 antagonist | 0.323 0.005 DBMET00052 0.63 0.004 DBMET00053 0.334 0.005 DBMET00482 | DBMET00053 | |
| 0.573 | 0.009 | 0.573 | Calcium channel L-type activator | 0.51 0.024 DBMET00052 0.262 0.193 DBMET00053 | ||
| 0.536 | 0.01 | 0.577 | Anticonvulsant | 0.51 0.012 DBMET00052 0.577 0.008 DBMET00053 0.55 0.009 DBMET00482 | DBMET00053 | |
| 0.516 | 0.004 | 0.516 | Alpha 2b adrenoreceptor antagonist | 0.251 0.014 DBMET00052 0.316 0.008 DBMET00053 0.138 0.045 DBMET00482 | ||
| 0.571 | 0.062 | 0.721 | Antiinflammatory | 0.671 0.036 DBMET00052 0.648 0.041 DBMET00053 0.721 0.027 DBMET00482 | DBMET00482 | |
| 0.517 | 0.007 | 0.517 | P-glycoprotein inhibitor | 0.489 0.009 DBMET00052 0.487 0.009 DBMET00053 0.461 0.011 DBMET00482 | ||
| 0.503 | 0.004 | 0.503 | 5 Hydroxytryptamine uptake inhibitor | 0.428 0.005 DBMET00052 0.19 0.012 DBMET00053 0.177 0.013 DBMET00482 | ||
| 0.491 | 0.003 | 0.491 | Adrenaline uptake inhibitor | 0.453 0.004 DBMET00052 0.203 0.006 DBMET00053 0.229 0.005 DBMET00482 | ||
| 0.499 | 0.029 | 0.547 | Histamine release inhibitor | 0.483 0.035 DBMET00052 0.547 0.017 DBMET00053 0.529 0.02 DBMET00482 | DBMET00053 | |
| 0.471 | 0.004 | 0.471 | Nav1.3 sodium channel blocker | 0.22 0.019 DBMET00052 0.313 0.008 DBMET00053 0.138 0.056 DBMET00482 | ||
| 0.472 | 0.005 | 0.472 | Nav1.2 sodium channel blocker | 0.289 0.016 DBMET00052 0.428 0.006 DBMET00053 0.263 0.02 DBMET00482 | ||
| 0.484 | 0.041 | 0.484 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.355 0.145 DBMET00052 0.4 0.101 DBMET00053 | ||
| 0.445 | 0.012 | 0.469 | Anesthetic general | 0.385 0.018 DBMET00052 0.469 0.01 DBMET00053 0.407 0.015 DBMET00482 | DBMET00053 | |
| 0.426 | 0.004 | 0.426 | Alpha 2a adrenoreceptor antagonist | 0.19 0.015 DBMET00052 0.269 0.008 DBMET00053 0.112 0.032 DBMET00482 | ||
| 0.424 | 0.003 | 0.424 | 5 Hydroxytryptamine 5A antagonist | 0.082 0.023 DBMET00052 0.279 0.004 DBMET00053 0.064 0.038 DBMET00482 | ||
| 0.406 | 0.004 | 0.406 | Alpha 2c adrenoreceptor antagonist | 0.175 0.023 DBMET00052 0.252 0.01 DBMET00053 0.107 0.059 DBMET00482 | ||
| 0.401 | 0.003 | 0.401 | 5 Hydroxytryptamine 5 antagonist | 0.072 0.025 DBMET00052 0.26 0.004 DBMET00053 0.056 0.044 DBMET00482 | ||
| 0.4 | 0.005 | 0.4 | Alpha 2 adrenoreceptor antagonist | 0.212 0.016 DBMET00052 0.247 0.012 DBMET00053 0.121 0.036 DBMET00482 | ||
| 0.441 | 0.055 | 0.579 | Transcription factor NF kappa B inhibitor | 0.573 0.035 DBMET00052 0.447 0.053 DBMET00053 0.579 0.034 DBMET00482 | DBMET00482 | |
| 0.431 | 0.046 | 0.431 | Vasodilator, peripheral | 0.36 0.069 DBMET00052 0.29 0.102 DBMET00053 0.23 0.144 DBMET00482 | ||
| 0.401 | 0.021 | 0.488 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.295 0.068 DBMET00052 0.488 0.008 DBMET00053 0.36 0.032 DBMET00482 | DBMET00053 | |
| 0.372 | 0.003 | 0.372 | Sphingomyelinase inhibitor | 0.262 0.004 DBMET00052 0.262 0.004 DBMET00053 0.205 0.009 DBMET00482 | ||
| 0.365 | 0.008 | 0.365 | Acetylcholine M1 receptor antagonist | 0.303 0.014 DBMET00052 0.364 0.008 DBMET00053 0.303 0.014 DBMET00482 | ||
| 0.354 | 0.009 | 0.354 | Anesthetic local | 0.286 0.014 DBMET00052 0.238 0.022 DBMET00053 0.193 0.034 DBMET00482 | ||
| 0.344 | 0.008 | 0.344 | Antihistaminic | 0.179 0.025 DBMET00052 0.193 0.022 DBMET00053 0.098 0.057 DBMET00482 | ||
| 0.361 | 0.028 | 0.361 | Sigma receptor agonist | 0.15 0.085 DBMET00052 0.206 0.06 DBMET00053 | ||
| 0.338 | 0.008 | 0.338 | Histamine antagonist | 0.158 0.027 DBMET00052 0.184 0.022 DBMET00053 0.082 0.062 DBMET00482 | ||
| 0.42 | 0.099 | 0.464 | Caspase 9 stimulant | 0.363 0.136 DBMET00052 0.464 0.076 DBMET00053 0.409 0.106 DBMET00482 | DBMET00053 | |
| 0.387 | 0.067 | 0.419 | GABA C receptor rho-3 antagonist | 0.204 0.202 DBMET00052 0.419 0.053 DBMET00053 0.231 0.173 DBMET00482 | DBMET00053 | |
| 0.333 | 0.014 | 0.333 | 5 Hydroxytryptamine 2 antagonist | 0.122 0.058 DBMET00052 0.196 0.032 DBMET00053 | ||
| 0.358 | 0.045 | 0.358 | Calcium channel activator | 0.342 0.055 DBMET00052 0.31 0.082 DBMET00053 0.293 0.099 DBMET00482 | ||
| 0.324 | 0.013 | 0.324 | 5 Hydroxytryptamine 2B antagonist | 0.144 0.044 DBMET00052 0.24 0.02 DBMET00053 0.117 0.064 DBMET00482 | ||
| 0.31 | 0.006 | 0.31 | Histamine H1 receptor antagonist | 0.239 0.01 DBMET00052 0.213 0.013 DBMET00053 0.161 0.021 DBMET00482 | ||
| 0.317 | 0.013 | 0.317 | Cholinergic antagonist | 0.317 0.013 DBMET00052 0.262 0.019 DBMET00053 0.263 0.019 DBMET00482 | ||
| 0.315 | 0.012 | 0.383 | Adenylate cyclase inhibitor | 0.298 0.014 DBMET00052 0.383 0.008 DBMET00053 0.359 0.009 DBMET00482 | DBMET00053 | |
| 0.311 | 0.013 | 0.311 | Antiadrenergic | 0.184 0.028 DBMET00052 0.201 0.024 DBMET00053 0.112 0.049 DBMET00482 | ||
| 0.307 | 0.013 | 0.307 | Antipruritic | 0.215 0.04 DBMET00052 0.306 0.013 DBMET00053 0.214 0.04 DBMET00482 | ||
| 0.349 | 0.056 | 0.356 | Vasodilator, coronary | 0.356 0.052 DBMET00052 0.299 0.089 DBMET00053 0.305 0.083 DBMET00482 | DBMET00052 | |
| 0.313 | 0.022 | 0.313 | 5 Hydroxytryptamine 1E antagonist | 0.185 0.148 DBMET00052 0.266 0.058 DBMET00053 | ||
| 0.29 | 0.006 | 0.29 | 5 Hydroxytryptamine 3E antagonist | 0.195 0.071 DBMET00052 0.271 0.009 DBMET00053 0.182 0.101 DBMET00482 | ||
| 0.295 | 0.014 | 0.295 | Acetylcholine antagonist | 0.269 0.017 DBMET00052 0.25 0.02 DBMET00053 0.23 0.024 DBMET00482 | ||
| 0.345 | 0.066 | 0.381 | Antithrombotic | 0.307 0.083 DBMET00052 0.381 0.054 DBMET00053 0.34 0.068 DBMET00482 | DBMET00053 | |
| 0.293 | 0.016 | 0.293 | Alpha adrenoreceptor antagonist | 0.16 0.035 DBMET00052 0.153 0.037 DBMET00053 0.077 0.075 DBMET00482 | ||
| 0.297 | 0.025 | 0.333 | Peptidyltransferase inhibitor | 0.319 0.019 DBMET00052 0.315 0.02 DBMET00053 0.333 0.015 DBMET00482 | DBMET00482 | |
| 0.285 | 0.014 | 0.285 | Adrenaline antagonist | 0.169 0.03 DBMET00052 0.183 0.027 DBMET00053 0.101 0.053 DBMET00482 | ||
| 0.28 | 0.01 | 0.28 | 5 Hydroxytryptamine 2C antagonist | 0.106 0.042 DBMET00052 0.19 0.019 DBMET00053 | ||
| 0.265 | 0.005 | 0.265 | 5 Hydroxytryptamine 1D antagonist | 0.078 0.032 DBMET00052 0.174 0.009 DBMET00053 | ||
| 0.27 | 0.012 | 0.27 | Acetylcholine muscarinic antagonist | 0.264 0.013 DBMET00052 0.237 0.017 DBMET00053 0.232 0.018 DBMET00482 | ||
| 0.261 | 0.004 | 0.261 | Histamine H2 receptor antagonist | 0.108 0.028 DBMET00052 0.15 0.01 DBMET00053 | ||
| 0.267 | 0.013 | 0.267 | 5 Hydroxytryptamine 2A antagonist | 0.075 0.063 DBMET00052 0.151 0.028 DBMET00053 | ||
| 0.259 | 0.009 | 0.259 | Alpha 1b adrenoreceptor antagonist | 0.141 0.024 DBMET00053 | ||
| 0.287 | 0.04 | 0.352 | Tyrosine 3 hydroxylase inhibitor | 0.221 0.102 DBMET00052 0.352 0.015 DBMET00053 0.275 0.048 DBMET00482 | DBMET00053 | |
| 0.249 | 0.006 | 0.249 | 5 Hydroxytryptamine 1B antagonist | 0.067 0.043 DBMET00052 0.148 0.013 DBMET00053 | ||
| 0.265 | 0.023 | 0.265 | 5 Hydroxytryptamine antagonist | 0.111 0.07 DBMET00052 0.16 0.045 DBMET00053 | ||
| 0.244 | 0.008 | 0.244 | Dopamine D1 antagonist | 0.111 0.022 DBMET00052 0.159 0.014 DBMET00053 0.075 0.036 DBMET00482 | ||
| 0.247 | 0.014 | 0.247 | ATPase inhibitor | 0.242 0.016 DBMET00052 0.173 0.067 DBMET00053 0.168 0.073 DBMET00482 | ||
| 0.28 | 0.06 | 0.39 | Platelet antagonist | 0.267 0.065 DBMET00052 0.39 0.029 DBMET00053 0.349 0.038 DBMET00482 | DBMET00053 | |
| 0.231 | 0.012 | 0.27 | Nav1.4 sodium channel blocker | 0.193 0.021 DBMET00052 0.27 0.005 DBMET00053 0.24 0.01 DBMET00482 | DBMET00053 | |
| 0.224 | 0.006 | 0.232 | Adenylate cyclase stimulant | 0.232 0.005 DBMET00052 0.22 0.007 DBMET00053 0.228 0.005 DBMET00482 | DBMET00052 | |
| 0.221 | 0.005 | 0.221 | Acetylcholine M4 receptor antagonist | 0.093 0.034 DBMET00052 0.171 0.008 DBMET00053 0.078 0.048 DBMET00482 | ||
| 0.22 | 0.008 | 0.22 | Alpha 1d adrenoreceptor antagonist | 0.114 0.02 DBMET00053 | ||
| 0.239 | 0.033 | 0.239 | RET inhibitor | 0.152 0.06 DBMET00052 0.212 0.04 DBMET00053 0.13 0.072 DBMET00482 | ||
| 0.264 | 0.061 | 0.264 | HERG channel blocker | 0.204 0.088 DBMET00053 | ||
| 0.261 | 0.067 | 0.261 | Gastrin inhibitor | 0.238 0.094 DBMET00052 0.205 0.142 DBMET00053 | ||
| 0.208 | 0.016 | 0.208 | 5 Hydroxytryptamine 1 antagonist | 0.081 0.047 DBMET00052 0.114 0.032 DBMET00053 | ||
| 0.256 | 0.064 | 0.256 | Potassium channel (Voltage-sensitive) blocker | 0.179 0.112 DBMET00053 | ||
| 0.2 | 0.008 | 0.2 | Beta tubulin antagonist | 0.188 0.008 DBMET00052 0.173 0.01 DBMET00053 0.166 0.01 DBMET00482 | ||
| 0.196 | 0.006 | 0.196 | Toll-Like receptor 3 antagonist | 0.12 0.03 DBMET00052 0.089 0.072 DBMET00053 | ||
| 0.206 | 0.02 | 0.206 | Alpha 1 adrenoreceptor antagonist | 0.096 0.045 DBMET00052 0.093 0.046 DBMET00053 | ||
| 0.259 | 0.075 | 0.315 | DNA damaging | 0.218 0.102 DBMET00052 0.315 0.052 DBMET00053 0.269 0.071 DBMET00482 | DBMET00053 | |
| 0.187 | 0.005 | 0.187 | Acetylcholine M5 receptor antagonist | 0.099 0.018 DBMET00052 0.128 0.011 DBMET00053 0.065 0.036 DBMET00482 | ||
| 0.255 | 0.076 | 0.337 | 5 Hydroxytryptamine uptake stimulant | 0.21 0.134 DBMET00052 0.337 0.029 DBMET00053 0.274 0.06 DBMET00482 | DBMET00053 | |
| 0.209 | 0.031 | 0.209 | Acetylcholinesterase inhibitor | 0.181 0.039 DBMET00052 0.112 0.086 DBMET00053 0.112 0.087 DBMET00482 | ||
| 0.195 | 0.017 | 0.195 | Alpha 1a adrenoreceptor antagonist | 0.086 0.042 DBMET00052 0.088 0.041 DBMET00053 | ||
| 0.188 | 0.012 | 0.188 | Nitric-oxide synthase inhibitor | 0.12 0.038 DBMET00052 0.187 0.012 DBMET00053 0.119 0.039 DBMET00482 | ||
| 0.261 | 0.087 | 0.277 | Insulysin inhibitor | 0.277 0.074 DBMET00053 | DBMET00053 | |
| 0.19 | 0.016 | 0.212 | Mediator release inhibitor | 0.158 0.025 DBMET00052 0.212 0.013 DBMET00053 0.174 0.02 DBMET00482 | DBMET00053 | |
| 0.213 | 0.041 | 0.213 | Cholinergic | 0.21 0.042 DBMET00052 0.118 0.11 DBMET00482 | ||
| 0.185 | 0.015 | 0.185 | Nav1.5 sodium channel blocker | 0.104 0.078 DBMET00052 0.178 0.017 DBMET00053 0.1 0.085 DBMET00482 | ||
| 0.199 | 0.029 | 0.199 | GABA C receptor rho-2 antagonist | 0.158 0.063 DBMET00053 | ||
| 0.177 | 0.008 | 0.201 | Acetylcholine M3 receptor antagonist | 0.201 0.007 DBMET00052 0.124 0.014 DBMET00053 0.151 0.011 DBMET00482 | DBMET00052 | |
| 0.227 | 0.064 | 0.239 | Platelet aggregation inhibitor | 0.239 0.057 DBMET00053 | DBMET00053 | |
| 0.171 | 0.008 | 0.239 | Dopamine uptake inhibitor | 0.239 0.005 DBMET00052 0.098 0.019 DBMET00053 0.138 0.011 DBMET00482 | DBMET00052 | |
| 0.319 | 0.159 | 0.477 | Apoptosis agonist | 0.477 0.082 DBMET00052 0.238 0.227 DBMET00053 0.446 0.093 DBMET00482 | DBMET00052 | |
| 0.242 | 0.085 | 0.328 | Interleukin agonist | 0.258 0.073 DBMET00052 0.312 0.042 DBMET00053 0.328 0.036 DBMET00482 | DBMET00482 | |
| 0.158 | 0.005 | 0.158 | Beta 3 adrenoreceptor antagonist | 0.134 0.007 DBMET00052 0.099 0.015 DBMET00053 0.08 0.023 DBMET00482 | ||
| 0.162 | 0.01 | 0.162 | Acetylcholine M2 receptor antagonist | 0.082 0.028 DBMET00052 0.137 0.013 DBMET00053 0.07 0.037 DBMET00482 | ||
| 0.161 | 0.009 | 0.161 | Glutamate (mGluR7) agonist | 0.129 0.022 DBMET00052 0.119 0.031 DBMET00053 0.096 0.068 DBMET00482 | ||
| 0.165 | 0.016 | 0.229 | GABA C receptor rho-1 antagonist | 0.1 0.063 DBMET00052 0.229 0.005 DBMET00053 0.143 0.024 DBMET00482 | DBMET00053 | |
| 0.236 | 0.088 | 0.33 | Aldehyde oxidase inhibitor | 0.156 0.134 DBMET00052 0.33 0.059 DBMET00053 0.22 0.095 DBMET00482 | DBMET00053 | |
| 0.161 | 0.022 | 0.221 | Gastric antisecretory | 0.221 0.009 DBMET00052 0.092 0.076 DBMET00053 0.135 0.034 DBMET00482 | DBMET00052 | |
| 0.18 | 0.041 | 0.18 | Sodium channel blocker | 0.166 0.047 DBMET00053 | ||
| 0.162 | 0.025 | 0.162 | Papain-like protease (SARS coronavirus) inhibitor | 0.144 0.04 DBMET00052 0.143 0.041 DBMET00053 0.129 0.063 DBMET00482 | ||
| 0.161 | 0.025 | 0.275 | GABA C receptor antagonist | 0.107 0.068 DBMET00052 0.275 0.005 DBMET00053 0.184 0.017 DBMET00482 | DBMET00053 | |
| 0.179 | 0.044 | 0.248 | Cytokine production inhibitor | 0.248 0.024 DBMET00053 | DBMET00053 | |
| 0.149 | 0.015 | 0.149 | Dopamine D3 antagonist | 0.076 0.034 DBMET00053 | ||
| 0.157 | 0.024 | 0.157 | Dopamine antagonist | 0.095 0.041 DBMET00053 | ||
| 0.152 | 0.02 | 0.152 | 5 Hydroxytryptamine 1A antagonist | 0.064 0.049 DBMET00052 0.101 0.032 DBMET00053 | ||
| 0.145 | 0.016 | 0.145 | Dopamine agonist | 0.059 0.053 DBMET00052 0.116 0.021 DBMET00053 | ||
| 0.144 | 0.016 | 0.167 | Histamine N-methyltransferase inhibitor | 0.083 0.064 DBMET00052 0.167 0.009 DBMET00053 0.108 0.039 DBMET00482 | DBMET00053 | |
| 0.168 | 0.043 | 0.168 | Sodium channel (voltage-gated) blocker | 0.162 0.046 DBMET00053 | ||
| 0.163 | 0.041 | 0.163 | Nav1.6 sodium channel blocker | 0.153 0.05 DBMET00053 | ||
| 0.145 | 0.024 | 0.155 | Prolactin inhibitor | 0.083 0.077 DBMET00052 0.155 0.02 DBMET00053 0.089 0.067 DBMET00482 | DBMET00053 | |
| 0.153 | 0.033 | 0.497 | GABA C receptor agonist | 0.101 0.065 DBMET00052 0.497 0.004 DBMET00053 0.358 0.006 DBMET00482 | DBMET00053 | |
| 0.17 | 0.051 | 0.17 | Toll-Like receptor 9 antagonist | |||
| 0.165 | 0.048 | 0.165 | Calcium channel blocker | 0.119 0.089 DBMET00053 | ||
| 0.217 | 0.1 | 0.46 | Superoxide dismutase inhibitor | 0.174 0.15 DBMET00052 0.46 0.017 DBMET00053 0.371 0.032 DBMET00482 | DBMET00053 | |
| 0.182 | 0.069 | 0.182 | Lipocortins synthesis antagonist | 0.175 0.076 DBMET00052 0.18 0.071 DBMET00053 0.173 0.078 DBMET00482 | ||
| 0.121 | 0.01 | 0.121 | 5 Hydroxytryptamine 6 antagonist | 0.104 0.014 DBMET00053 | ||
| 0.124 | 0.015 | 0.124 | Calcium channel L-type blocker | 0.074 0.046 DBMET00052 0.089 0.031 DBMET00053 | ||
| 0.116 | 0.011 | 0.14 | Beta adrenoreceptor antagonist | 0.14 0.007 DBMET00052 0.083 0.025 DBMET00053 0.106 0.014 DBMET00482 | DBMET00052 | |
| 0.111 | 0.009 | 0.143 | Dopamine transporter inhibitor | 0.143 0.006 DBMET00052 0.054 0.029 DBMET00053 0.101 0.012 DBMET00482 | DBMET00052 | |
| 0.11 | 0.008 | 0.11 | Beta 1 adrenoreceptor antagonist | 0.095 0.011 DBMET00052 0.076 0.021 DBMET00053 0.066 0.029 DBMET00482 | ||
| 0.105 | 0.005 | 0.105 | 5 Hydroxytryptamine 3B antagonist | 0.072 0.008 DBMET00053 | ||
| 0.188 | 0.089 | 0.2 | Neurotrophic factor enhancer | 0.2 0.076 DBMET00052 0.184 0.093 DBMET00053 0.196 0.08 DBMET00482 | DBMET00052 | |
| 0.166 | 0.069 | 0.195 | Neurotensin receptor agonist | 0.195 0.038 DBMET00053 0.153 0.095 DBMET00482 | DBMET00053 | |
| 0.101 | 0.006 | 0.101 | 5 Hydroxytryptamine 4 antagonist | 0.067 0.019 DBMET00052 0.098 0.007 DBMET00053 0.063 0.021 DBMET00482 | ||
| 0.098 | 0.008 | 0.103 | Beta 2 adrenoreceptor antagonist | 0.103 0.008 DBMET00052 0.072 0.015 DBMET00053 0.075 0.014 DBMET00482 | DBMET00052 | |
| 0.116 | 0.028 | 0.116 | Dopamine D2 antagonist | 0.079 0.04 DBMET00053 | ||
| 0.187 | 0.101 | 0.187 | Potassium channel blocker | |||
| 0.09 | 0.005 | 0.09 | Adenylate cyclase 1 inhibitor | 0.076 0.009 DBMET00052 0.089 0.005 DBMET00053 0.075 0.01 DBMET00482 | ||
| 0.125 | 0.041 | 0.125 | Acetylcholine release stimulant | 0.097 0.094 DBMET00053 | ||
| 0.147 | 0.064 | 0.162 | Histone deacetylase SIRT1 inhibitor | 0.162 0.052 DBMET00053 | DBMET00053 | |
| 0.09 | 0.009 | 0.09 | 5 Hydroxytryptamine 1B agonist | 0.064 0.023 DBMET00053 | ||
| 0.111 | 0.029 | 0.117 | Glutamate release inhibitor | 0.117 0.024 DBMET00053 0.084 0.079 DBMET00482 | DBMET00053 | |
| 0.111 | 0.031 | 0.151 | CYP2A6 inhibitor | 0.151 0.016 DBMET00053 0.067 0.064 DBMET00482 | DBMET00053 | |
| 0.102 | 0.022 | 0.147 | Protein kinase C alpha inhibitor | 0.069 0.045 DBMET00052 0.147 0.011 DBMET00053 0.091 0.026 DBMET00482 | DBMET00053 | |
| 0.136 | 0.056 | 0.136 | Vanilloid 1 agonist | 0.121 0.085 DBMET00052 0.13 0.066 DBMET00053 0.115 0.1 DBMET00482 | ||
| 0.116 | 0.037 | 0.178 | Alcohol dehydrogenase inhibitor | 0.102 0.05 DBMET00052 0.178 0.015 DBMET00053 0.149 0.021 DBMET00482 | DBMET00053 | |
| 0.124 | 0.045 | 0.124 | Nav1.1 sodium channel blocker | |||
| 0.147 | 0.07 | 0.253 | Protein kinase stimulant | 0.189 0.046 DBMET00052 0.2 0.042 DBMET00053 0.253 0.026 DBMET00482 | DBMET00482 | |
| 0.107 | 0.031 | 0.107 | Inducible nitric-oxide synthase inhibitor | 0.082 0.059 DBMET00052 0.107 0.031 DBMET00053 0.082 0.059 DBMET00482 | ||
| 0.079 | 0.004 | 0.079 | Histamine H1 receptor agonist | 0.042 0.034 DBMET00052 0.068 0.005 DBMET00053 | ||
| 0.104 | 0.029 | 0.122 | Glycine receptor antagonist | 0.122 0.017 DBMET00052 0.094 0.039 DBMET00053 0.112 0.023 DBMET00482 | DBMET00052 | |
| 0.169 | 0.096 | 0.301 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.301 0.043 DBMET00053 | DBMET00053 | |
| 0.142 | 0.069 | 0.162 | Heat shock protein 70 antagonist | 0.132 0.111 DBMET00052 0.162 0.025 DBMET00053 0.15 0.044 DBMET00482 | DBMET00053 | |
| 0.09 | 0.018 | 0.09 | Alpha 2 adrenoreceptor agonist | 0.071 0.031 DBMET00053 | ||
| 0.079 | 0.008 | 0.079 | Histamine H2 receptor agonist | 0.063 0.013 DBMET00053 | ||
| 0.092 | 0.02 | 0.092 | Phospholipase D inhibitor | 0.068 0.059 DBMET00052 0.066 0.062 DBMET00053 | ||
| 0.082 | 0.012 | 0.124 | Opioid kappa receptor agonist | 0.097 0.01 DBMET00052 0.112 0.008 DBMET00053 0.124 0.007 DBMET00482 | DBMET00482 | |
| 0.097 | 0.028 | 0.097 | Estrogen-related receptor beta agonist | 0.089 0.043 DBMET00052 0.088 0.045 DBMET00053 0.08 0.068 DBMET00482 | ||
| 0.131 | 0.062 | 0.156 | Cathepsin H inhibitor | 0.104 0.1 DBMET00052 0.156 0.042 DBMET00053 0.127 0.067 DBMET00482 | DBMET00053 | |
| 0.121 | 0.055 | 0.121 | Calcium channel (voltage-sensitive) blocker | |||
| 0.079 | 0.013 | 0.079 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.047 DBMET00052 0.049 0.045 DBMET00053 | ||
| 0.133 | 0.068 | 0.143 | Tubulin antagonist | 0.138 0.064 DBMET00052 0.139 0.064 DBMET00053 0.143 0.061 DBMET00482 | DBMET00482 | |
| 0.069 | 0.004 | 0.069 | Melatonin receptor 1A agonist | 0.039 0.015 DBMET00053 | ||
| 0.137 | 0.072 | 0.181 | Neurotrophic factor | 0.178 0.039 DBMET00052 0.136 0.073 DBMET00053 0.181 0.037 DBMET00482 | DBMET00482 | |
| 0.069 | 0.007 | 0.069 | Alpha 1d adrenoreceptor agonist | 0.067 0.008 DBMET00053 | ||
| 0.096 | 0.035 | 0.098 | Nicotinic alpha4beta2 receptor antagonist | 0.098 0.033 DBMET00053 | DBMET00053 | |
| 0.086 | 0.027 | 0.105 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.105 0.01 DBMET00053 0.085 0.029 DBMET00482 | DBMET00053 | |
| 0.083 | 0.023 | 0.086 | 5 Hydroxytryptamine 3 antagonist | 0.086 0.022 DBMET00053 | DBMET00053 | |
| 0.138 | 0.08 | 0.154 | Ca2+-transporting ATPase inhibitor | 0.143 0.063 DBMET00052 0.149 0.045 DBMET00053 0.154 0.034 DBMET00482 | DBMET00482 | |
| 0.101 | 0.043 | 0.13 | Ornithine decarboxylase inhibitor | 0.103 0.041 DBMET00052 0.128 0.02 DBMET00053 0.13 0.019 DBMET00482 | DBMET00482 | |
| 0.086 | 0.03 | 0.086 | Dopamine D4 antagonist | 0.058 0.044 DBMET00053 | ||
| 0.08 | 0.024 | 0.088 | Androgen agonist | 0.087 0.02 DBMET00052 0.081 0.024 DBMET00053 0.088 0.02 DBMET00482 | DBMET00482 | |
| 0.108 | 0.053 | 0.135 | Anabolic | 0.122 0.038 DBMET00052 0.121 0.038 DBMET00053 0.135 0.027 DBMET00482 | DBMET00482 | |
| 0.071 | 0.017 | 0.071 | Potassium channel (Inward rectifier) blocker | 0.044 0.043 DBMET00052 0.044 0.043 DBMET00053 | ||
| 0.126 | 0.072 | 0.183 | Alpha-N-acetylglucosaminidase inhibitor | 0.17 0.045 DBMET00052 0.135 0.064 DBMET00053 0.183 0.039 DBMET00482 | DBMET00482 | |
| 0.19 | 0.138 | 0.244 | DNA synthesis inhibitor | 0.221 0.093 DBMET00052 0.212 0.105 DBMET00053 0.244 0.07 DBMET00482 | DBMET00482 | |
| 0.094 | 0.043 | 0.094 | Acetylcholine nicotinic antagonist | 0.078 0.056 DBMET00053 | ||
| 0.066 | 0.016 | 0.066 | Squalene epoxidase inhibitor | 0.061 0.02 DBMET00052 0.058 0.023 DBMET00053 0.053 0.029 DBMET00482 | ||
| 0.089 | 0.038 | 0.101 | Analgesic, opioid | 0.101 0.031 DBMET00052 0.087 0.04 DBMET00053 0.1 0.031 DBMET00482 | DBMET00052 | |
| 0.063 | 0.013 | 0.238 | Kinesin antagonist | 0.238 0.004 DBMET00053 0.121 0.005 DBMET00482 | DBMET00053 | |
| 0.063 | 0.013 | 0.238 | Kinesin-like protein 1 inhibitor | 0.238 0.004 DBMET00053 0.121 0.005 DBMET00482 | DBMET00053 | |
| 0.189 | 0.14 | 0.238 | Neuropeptide Y2 antagonist | 0.238 0.068 DBMET00053 | DBMET00053 | |
| 0.068 | 0.021 | 0.072 | 5 Hydroxytryptamine 7 agonist | 0.072 0.018 DBMET00053 | DBMET00053 | |
| 0.059 | 0.012 | 0.128 | Dopamine D5 agonist | 0.128 0.003 DBMET00053 0.072 0.008 DBMET00482 | DBMET00053 | |
| 0.103 | 0.056 | 0.177 | Creatine kinase inhibitor | 0.113 0.046 DBMET00052 0.163 0.019 DBMET00053 0.177 0.015 DBMET00482 | DBMET00482 | |
| 0.159 | 0.113 | 0.349 | Antimitotic | 0.244 0.062 DBMET00052 0.285 0.048 DBMET00053 0.349 0.032 DBMET00482 | DBMET00482 | |
| 0.064 | 0.018 | 0.064 | Immunoglobulin Fc receptor antagonist | 0.059 0.027 DBMET00053 | ||
| 0.067 | 0.021 | 0.067 | Histamine agonist | 0.058 0.03 DBMET00053 | ||
| 0.067 | 0.021 | 0.067 | 5 Hydroxytryptamine 2 agonist | 0.065 0.022 DBMET00053 | ||
| 0.113 | 0.068 | 0.129 | Estrogen antagonist | 0.129 0.039 DBMET00052 0.107 0.081 DBMET00053 0.128 0.042 DBMET00482 | DBMET00052 | |
| 0.082 | 0.037 | 0.082 | Vanilloid 4 agonist | 0.071 0.062 DBMET00052 | ||
| 0.075 | 0.032 | 0.093 | 5 Hydroxytryptamine 2A agonist | 0.093 0.018 DBMET00053 | DBMET00053 | |
| 0.115 | 0.073 | 0.18 | Alkylator | 0.18 0.033 DBMET00052 0.113 0.075 DBMET00053 0.177 0.034 DBMET00482 | DBMET00052 | |
| 0.064 | 0.023 | 0.064 | Thromboxane synthase inhibitor | 0.051 0.045 DBMET00052 0.055 0.036 DBMET00053 | ||
| 0.079 | 0.038 | 0.079 | Alpha adrenoreceptor agonist | |||
| 0.073 | 0.033 | 0.094 | NMDA receptor agonist | 0.094 0.022 DBMET00053 | DBMET00053 | |
| 0.116 | 0.077 | 0.127 | MAO inhibitor | 0.127 0.071 DBMET00053 | DBMET00053 | |
| 0.15 | 0.112 | 0.189 | Succinate dehydrogenase inhibitor | 0.189 0.058 DBMET00053 0.153 0.107 DBMET00482 | DBMET00053 | |
| 0.107 | 0.068 | 0.165 | 5 Hydroxytryptamine 3A agonist | 0.165 0.028 DBMET00053 | DBMET00053 | |
| 0.077 | 0.039 | 0.077 | Neuronal nicotinic receptor antagonist | 0.063 0.051 DBMET00053 | ||
| 0.169 | 0.132 | 0.187 | Vasodilator | 0.187 0.115 DBMET00052 | DBMET00052 | |
| 0.076 | 0.041 | 0.113 | Phenylalanine 4-hydroxylase inhibitor | 0.067 0.049 DBMET00052 0.113 0.02 DBMET00053 0.1 0.025 DBMET00482 | DBMET00053 | |
| 0.061 | 0.027 | 0.069 | Epithelial sodium channel blocker | 0.069 0.019 DBMET00053 | DBMET00053 | |
| 0.199 | 0.165 | 0.251 | Cholesterol antagonist | 0.25 0.125 DBMET00052 0.201 0.164 DBMET00053 0.251 0.124 DBMET00482 | DBMET00482 | |
| 0.067 | 0.034 | 0.067 | Carbonic anhydrase stimulant | 0.064 0.036 DBMET00053 | ||
| 0.11 | 0.077 | 0.11 | Calcium channel N-type blocker | |||
| 0.077 | 0.043 | 0.078 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 DBMET00052 0.078 0.039 DBMET00053 0.077 0.042 DBMET00482 | DBMET00053 | |
| 0.097 | 0.064 | 0.097 | Butyrylcholinesterase inhibitor | |||
| 0.045 | 0.013 | 0.045 | Melatonin 2 agonist | |||
| 0.1 | 0.068 | 0.101 | Factor V inhibitor | 0.101 0.066 DBMET00053 | DBMET00053 | |
| 0.066 | 0.034 | 0.066 | Histone deacetylase SIRT3 inhibitor | 0.066 0.034 DBMET00053 | ||
| 0.046 | 0.014 | 0.046 | Delayed rectifier potassium channel blocker | 0.041 0.02 DBMET00052 0.034 0.033 DBMET00053 | ||
| 0.107 | 0.076 | 0.135 | Photosensitizer | 0.135 0.042 DBMET00053 0.111 0.07 DBMET00482 | DBMET00053 | |
| 0.06 | 0.028 | 0.06 | Thromboxane A2 antagonist | 0.05 0.036 DBMET00053 | ||
| 0.084 | 0.053 | 0.084 | Adrenaline agonist | |||
| 0.047 | 0.018 | 0.047 | Histone deacetylase 9 inhibitor | |||
| 0.147 | 0.118 | 0.155 | Non-steroidal antiinflammatory agent | 0.155 0.109 DBMET00053 | DBMET00053 | |
| 0.042 | 0.013 | 0.042 | Melatonin agonist | |||
| 0.149 | 0.121 | 0.149 | I kappa B kinase epsilon inhibitor | |||
| 0.071 | 0.043 | 0.071 | Sphingosine 1-phosphate receptor 4 agonist | 0.065 0.049 DBMET00053 | ||
| 0.038 | 0.01 | 0.038 | Dopamine autoreceptor agonist | |||
| 0.077 | 0.051 | 0.159 | GABA aminotransferase inhibitor | 0.159 0.006 DBMET00053 0.113 0.019 DBMET00482 | DBMET00053 | |
| 0.059 | 0.033 | 0.059 | Thromboxane antagonist | 0.051 0.041 DBMET00053 | ||
| 0.036 | 0.011 | 0.036 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.073 | 0.049 | 0.093 | Aminopeptidase I inhibitor | 0.064 0.062 DBMET00052 0.093 0.032 DBMET00053 0.082 0.04 DBMET00482 | DBMET00053 | |
| 0.133 | 0.109 | 0.199 | Melanin inhibitor | 0.151 0.08 DBMET00052 0.173 0.057 DBMET00053 0.199 0.041 DBMET00482 | DBMET00482 | |
| 0.049 | 0.026 | 0.051 | Dopamine D5 antagonist | 0.051 0.025 DBMET00053 | DBMET00053 | |
| 0.205 | 0.182 | 0.205 | Ca(v)3.3 blocker | |||
| 0.039 | 0.016 | 0.039 | Melatonin 1 agonist | |||
| 0.048 | 0.026 | 0.048 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.055 | 0.033 | 0.059 | NMDA 2A receptor antagonist | 0.059 0.03 DBMET00053 | DBMET00053 | |
| 0.057 | 0.035 | 0.064 | Acyl-CoA dehydrogenase inhibitor | 0.063 0.031 DBMET00052 0.059 0.034 DBMET00053 0.064 0.03 DBMET00482 | DBMET00482 | |
| 0.096 | 0.075 | 0.193 | Ferrochelatase inhibitor | 0.193 0.024 DBMET00053 0.096 0.075 DBMET00482 | DBMET00053 | |
| 0.047 | 0.027 | 0.061 | Geranyltranstransferase inhibitor | 0.061 0.013 DBMET00053 0.046 0.028 DBMET00482 | DBMET00053 | |
| 0.114 | 0.095 | 0.114 | Toll-Like receptor antagonist | |||
| 0.051 | 0.032 | 0.051 | Alpha 1b adrenoreceptor agonist | |||
| 0.09 | 0.071 | 0.131 | Lanosterol 14 alpha demethylase inhibitor | 0.094 0.064 DBMET00052 0.128 0.024 DBMET00053 0.131 0.021 DBMET00482 | DBMET00482 | |
| 0.105 | 0.086 | 0.105 | Interleukin 8 antagonist | 0.103 0.091 DBMET00053 | ||
| 0.051 | 0.034 | 0.051 | Sigma receptor antagonist | |||
| 0.082 | 0.064 | 0.096 | Myeloperoxidase inhibitor | 0.096 0.041 DBMET00053 | DBMET00053 | |
| 0.103 | 0.086 | 0.131 | Microtubule formation inhibitor | 0.131 0.05 DBMET00052 0.115 0.066 DBMET00482 | DBMET00052 | |
| 0.081 | 0.064 | 0.081 | Ca(v)2.2 blocker | |||
| 0.08 | 0.064 | 0.08 | Calcium antagonist | |||
| 0.097 | 0.081 | 0.129 | GABA receptor agonist | 0.129 0.049 DBMET00053 | DBMET00053 | |
| 0.045 | 0.03 | 0.045 | Histamine H3 receptor antagonist | |||
| 0.125 | 0.11 | 0.139 | Neuropeptide Y1 antagonist | 0.139 0.082 DBMET00053 | DBMET00053 | |
| 0.037 | 0.022 | 0.055 | Opioid delta receptor agonist | 0.032 0.031 DBMET00052 0.055 0.011 DBMET00053 0.04 0.019 DBMET00482 | DBMET00053 | |
| 0.045 | 0.031 | 0.045 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.02 | 0.007 | 0.02 | NMDA receptor phencyclidine site antagonist | 0.016 0.01 DBMET00052 0.016 0.01 DBMET00053 | ||
| 0.022 | 0.009 | 0.022 | Alpha 2c adrenoreceptor agonist | 0.017 0.016 DBMET00053 | ||
| 0.079 | 0.067 | 0.079 | CC chemokine 5 receptor agonist | 0.078 0.073 DBMET00053 | ||
| 0.096 | 0.084 | 0.104 | Protein kinase C gamma inhibitor | 0.095 0.086 DBMET00052 0.104 0.07 DBMET00053 0.103 0.071 DBMET00482 | DBMET00053 | |
| 0.018 | 0.006 | 0.018 | Melatonin receptor 1A antagonist | |||
| 0.056 | 0.045 | 0.173 | CXC chemokine 4 receptor antagonist | 0.173 0.013 DBMET00053 | DBMET00053 | |
| 0.123 | 0.113 | 0.123 | Cyclin-dependent kinase 8 inhibitor | 0.123 0.113 DBMET00053 | ||
| 0.106 | 0.095 | 0.174 | Toll-Like receptor 2 antagonist | 0.174 0.037 DBMET00053 0.151 0.052 DBMET00482 | DBMET00053 | |
| 0.04 | 0.03 | 0.04 | Histone deacetylase 8 inhibitor | |||
| 0.037 | 0.027 | 0.044 | Diamine oxidase inhibitor | 0.044 0.019 DBMET00053 | DBMET00053 | |
| 0.031 | 0.021 | 0.031 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.025 DBMET00053 | ||
| 0.086 | 0.076 | 0.169 | Aminopeptidase B inhibitor | 0.169 0.03 DBMET00053 0.134 0.045 DBMET00482 | DBMET00053 | |
| 0.059 | 0.049 | 0.059 | Heme oxygenase stimulant | |||
| 0.075 | 0.066 | 0.075 | Opioid kappa receptor antagonist | |||
| 0.074 | 0.065 | 0.074 | Acetylcholine nicotinic agonist | |||
| 0.026 | 0.017 | 0.026 | Vanilloid 2 agonist | 0.025 0.019 DBMET00052 | ||
| 0.028 | 0.019 | 0.028 | Melatonin antagonist | |||
| 0.032 | 0.023 | 0.033 | Estrogen-related receptor beta antagonist | 0.031 0.026 DBMET00052 0.033 0.02 DBMET00053 0.032 0.023 DBMET00482 | DBMET00053 | |
| 0.034 | 0.025 | 0.053 | Retinoid X alpha receptor agonist | 0.053 0.013 DBMET00053 | DBMET00053 | |
| 0.126 | 0.118 | 0.147 | Arachidonic acid antagonist | 0.125 0.12 DBMET00052 0.147 0.092 DBMET00053 0.146 0.093 DBMET00482 | DBMET00053 | |
| 0.019 | 0.01 | 0.019 | Alpha 2a adrenoreceptor agonist | |||
| 0.019 | 0.01 | 0.019 | KiSS-1 receptor antagonist | |||
| 0.02 | 0.012 | 0.02 | Histamine H4 receptor agonist | 0.017 0.014 DBMET00053 | ||
| 0.017 | 0.009 | 0.027 | Thromboxane A2 agonist | 0.027 0.004 DBMET00052 0.016 0.009 DBMET00053 0.026 0.004 DBMET00482 | DBMET00052 | |
| 0.09 | 0.083 | 0.115 | Estrogen receptor beta antagonist | 0.114 0.04 DBMET00052 0.09 0.084 DBMET00053 0.115 0.038 DBMET00482 | DBMET00482 | |
| 0.037 | 0.03 | 0.043 | Membrane dipeptidase inhibitor | 0.043 0.023 DBMET00053 | DBMET00053 | |
| 0.028 | 0.021 | 0.028 | 5 Hydroxytryptamine 1D agonist | |||
| 0.138 | 0.132 | 0.222 | Phospholipase C inhibitor | 0.147 0.113 DBMET00052 0.207 0.04 DBMET00053 0.222 0.033 DBMET00482 | DBMET00482 | |
| 0.028 | 0.022 | 0.052 | AMPA 3 receptor antagonist | 0.052 0.008 DBMET00053 | DBMET00053 | |
| 0.031 | 0.025 | 0.049 | Sirtuin 2 inhibitor | 0.049 0.013 DBMET00053 | DBMET00053 | |
| 0.089 | 0.083 | 0.089 | Falcipain 3 inhibitor | |||
| 0.045 | 0.04 | 0.048 | Histamine H4 receptor antagonist | 0.048 0.035 DBMET00053 | DBMET00053 | |
| 0.047 | 0.043 | 0.085 | Opioid agonist | 0.059 0.03 DBMET00052 0.073 0.022 DBMET00053 0.085 0.017 DBMET00482 | DBMET00482 | |
| 0.076 | 0.072 | 0.077 | Acetylcholine agonist | 0.077 0.07 DBMET00052 | DBMET00052 | |
| 0.026 | 0.023 | 0.03 | Thrombin receptor antagonist | 0.03 0.017 DBMET00053 | DBMET00053 | |
| 0.063 | 0.061 | 0.089 | Exportin-1 inhibitor | 0.089 0.016 DBMET00053 | DBMET00053 | |
| 0.027 | 0.024 | 0.027 | Estrogen-related receptor gamma antagonist | |||
| 0.039 | 0.037 | 0.039 | Nerve growth factor antagonist | |||
| 0.026 | 0.023 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.025 0.024 DBMET00053 | ||
| 0.023 | 0.021 | 0.026 | Glutamate (mGluR1) agonist | 0.026 0.014 DBMET00053 | DBMET00053 | |
| 0.037 | 0.036 | 0.054 | Phenylethanolamine N methyltransferase inhibitor | 0.037 0.036 DBMET00052 0.054 0.011 DBMET00053 0.05 0.015 DBMET00482 | DBMET00053 | |
| 0.058 | 0.057 | 0.058 | Histone deacetylase inhibitor | |||
| 0.014 | 0.013 | 0.031 | Prostacyclin agonist | 0.024 0.007 DBMET00052 0.018 0.009 DBMET00053 0.031 0.005 DBMET00482 | DBMET00482 | |
| 0.017 | 0.016 | 0.017 | Melatonin 1 antagonist | |||
| 0.044 | 0.045 | 0.058 | Dopamine beta hydroxylase inhibitor | 0.058 0.017 DBMET00053 | DBMET00053 | |
| 0.026 | 0.027 | 0.037 | Purinergic P2Y15 antagonist | 0.031 0.015 DBMET00052 0.032 0.014 DBMET00053 0.037 0.009 DBMET00482 | DBMET00482 | |
| 0.037 | 0.039 | 0.04 | NMDA receptor subunit 3B antagonist | 0.04 0.035 DBMET00053 | DBMET00053 | |
| 0.064 | 0.066 | 0.125 | Glutamate dehydrogenase inhibitor | 0.07 0.056 DBMET00052 0.113 0.025 DBMET00053 0.125 0.021 DBMET00482 | DBMET00482 | |
| 0.126 | 0.129 | 0.151 | Amyloid beta aggregation inhibitor | 0.13 0.125 DBMET00052 0.151 0.107 DBMET00053 0.148 0.109 DBMET00482 | DBMET00053 | |
| 0.088 | 0.091 | 0.127 | Adenylate kinase inhibitor | 0.1 0.068 DBMET00052 0.111 0.053 DBMET00053 0.127 0.038 DBMET00482 | DBMET00482 | |
| 0.145 | 0.148 | 0.171 | Histone acetyltransferase inhibitor | 0.171 0.112 DBMET00053 | DBMET00053 | |
| 0.034 | 0.038 | 0.061 | GABA uptake inhibitor | 0.061 0.01 DBMET00053 0.036 0.033 DBMET00482 | DBMET00053 | |
| 0.034 | 0.04 | 0.054 | AMPA 4 receptor antagonist | 0.054 0.013 DBMET00053 | DBMET00053 | |
| 0.057 | 0.064 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.055 DBMET00052 | DBMET00052 | |
| 0.033 | 0.04 | 0.043 | Oxytocin agonist | 0.043 0.029 DBMET00053 | DBMET00053 | |
| 0.029 | 0.037 | 0.033 | NMDA receptor subunit 3A antagonist | 0.033 0.032 DBMET00482 | DBMET00482 | |
| 0.027 | 0.035 | 0.05 | Arginase inhibitor | 0.05 0.015 DBMET00053 0.049 0.015 DBMET00482 | DBMET00053 | |
| 0.016 | 0.025 | 0.033 | Imidazoline I1 receptor antagonist | 0.033 0.006 DBMET00053 | DBMET00053 | |
| 0.044 | 0.054 | 0.054 | Factor III inhibitor | 0.054 0.026 DBMET00053 0.047 0.042 DBMET00482 | DBMET00053 | |
| 0.085 | 0.094 | 0.168 | Carbonic anhydrase XV inhibitor | 0.168 0.025 DBMET00053 0.153 0.029 DBMET00482 | DBMET00053 | |
| 0.024 | 0.034 | 0.031 | Growth hormone releasing factor agonist | 0.031 0.025 DBMET00053 | DBMET00053 | |
| 0.033 | 0.045 | 0.052 | 5 Hydroxytryptamine 2B agonist | 0.052 0.012 DBMET00053 | DBMET00053 | |
| 0.078 | 0.09 | 0.111 | Chemokine receptor antagonist | 0.111 0.053 DBMET00053 | DBMET00053 | |
| 0.028 | 0.04 | 0.039 | Melanocortin 1 antagonist | 0.039 0.025 DBMET00053 | DBMET00053 | |
| 0.089 | 0.102 | 0.101 | Histone deacetylase class III inhibitor | 0.101 0.088 DBMET00053 | DBMET00053 | |
| 0.01 | 0.024 | 0.018 | CXC chemokine 4 receptor agonist | 0.018 0.008 DBMET00053 | DBMET00053 | |
| 0.023 | 0.04 | 0.032 | 5 Hydroxytryptamine 6 agonist | 0.032 0.015 DBMET00053 | DBMET00053 | |
| 0.018 | 0.036 | 0.034 | Urotensin II agonist | 0.034 0.013 DBMET00053 | DBMET00053 | |
| 0.028 | 0.046 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.037 0.021 DBMET00052 | DBMET00052 | |
| 0.022 | 0.04 | 0.04 | Retinoid X receptor agonist | 0.04 0.022 DBMET00053 | DBMET00053 | |
| 0.159 | 0.177 | 0.205 | RNA-directed DNA polymerase inhibitor | 0.205 0.093 DBMET00053 0.194 0.108 DBMET00482 | DBMET00053 | |
| 0.064 | 0.085 | 0.088 | Interferon agonist | 0.088 0.04 DBMET00053 0.084 0.046 DBMET00482 | DBMET00053 | |
| 0.074 | 0.095 | 0.091 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.05 DBMET00053 | DBMET00053 | |
| 0.042 | 0.064 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.034 DBMET00052 0.055 0.034 DBMET00482 | DBMET00482 | |
| 0.091 | 0.115 | 0.119 | Aldehyde dehydrogenase inhibitor | 0.119 0.072 DBMET00053 | DBMET00053 | |
| 0.005 | 0.029 | 0.012 | Thromboxane agonist | 0.01 0.008 DBMET00052 0.012 0.006 DBMET00482 | DBMET00482 | |
| 0.04 | 0.064 | 0.068 | Aconitate hydratase inhibitor | 0.068 0.02 DBMET00053 0.048 0.041 DBMET00482 | DBMET00053 | |
| 0.039 | 0.063 | 0.048 | Acetylcholine muscarinic agonist | 0.048 0.045 DBMET00052 | DBMET00052 | |
| 0.111 | 0.136 | 0.366 | Growth hormone agonist | 0.366 0.021 DBMET00053 0.318 0.029 DBMET00482 | DBMET00053 | |
| 0.186 | 0.211 | 0.194 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.194 0.184 DBMET00053 | DBMET00053 | |
| 0.052 | 0.078 | 0.081 | Sirtuin 1 inhibitor | 0.081 0.034 DBMET00053 | DBMET00053 | |
| 0.026 | 0.052 | 0.038 | Toll-Like receptor 2 agonist | 0.038 0.031 DBMET00053 | DBMET00053 | |
| 0.077 | 0.105 | 0.094 | Electrolyte absorption antagonist | 0.094 0.066 DBMET00053 | DBMET00053 | |
| 0.016 | 0.045 | 0.029 | Lysine carboxypeptidase inhibitor | 0.029 0.016 DBMET00053 | DBMET00053 | |
| 0.064 | 0.093 | 0.099 | NMDA receptor antagonist | 0.099 0.048 DBMET00053 0.092 0.052 DBMET00482 | DBMET00053 | |
| 0.067 | 0.097 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.035 DBMET00053 0.08 0.047 DBMET00482 | DBMET00053 | |
| 0.032 | 0.063 | 0.046 | Kainate receptor agonist | 0.046 0.019 DBMET00053 0.044 0.022 DBMET00482 | DBMET00053 | |
| 0.028 | 0.058 | 0.044 | Glycine transporter 2 inhibitor | 0.044 0.035 DBMET00053 | DBMET00053 | |
| 0.051 | 0.083 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.066 0.064 DBMET00052 0.1 0.032 DBMET00053 0.108 0.025 DBMET00482 | DBMET00482 | |
| 0.048 | 0.081 | 0.066 | I kappa B kinase 2 inhibitor | 0.066 0.037 DBMET00053 | DBMET00053 | |
| 0.047 | 0.08 | 0.059 | Potassium channel intermediate-conductance Ca-activated blocker | 0.059 0.044 DBMET00053 | DBMET00053 | |
| 0.084 | 0.117 | 0.129 | DOPA decarboxylase inhibitor | 0.129 0.036 DBMET00053 | DBMET00053 | |
| 0.03 | 0.065 | 0.039 | Plasmepsin II inhibitor | 0.039 0.033 DBMET00482 | DBMET00482 | |
| 0.036 | 0.071 | 0.047 | Parathyroid hormone antagonist | 0.047 0.027 DBMET00053 0.045 0.031 DBMET00482 | DBMET00053 | |
| 0.06 | 0.095 | 0.13 | Carbonic anhydrase VI inhibitor | 0.13 0.026 DBMET00053 0.127 0.027 DBMET00482 | DBMET00053 | |
| 0.068 | 0.104 | 0.169 | Topoisomerase I inhibitor | 0.128 0.051 DBMET00052 0.105 0.066 DBMET00053 0.169 0.035 DBMET00482 | DBMET00482 | |
| 0.03 | 0.066 | 0.048 | AMPA receptor antagonist | 0.048 0.033 DBMET00053 | DBMET00053 | |
| 0.036 | 0.073 | 0.067 | Argininosuccinate synthase inhibitor | 0.058 0.038 DBMET00053 0.067 0.032 DBMET00482 | DBMET00482 | |
| 0.048 | 0.085 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | 0.076 0.021 DBMET00053 | DBMET00053 | |
| 0.01 | 0.047 | 0.032 | AMPA 1 receptor antagonist | 0.032 0.019 DBMET00053 | DBMET00053 | |
| 0.065 | 0.103 | 0.126 | Protein kinase C delta inhibitor | 0.126 0.033 DBMET00053 0.093 0.058 DBMET00482 | DBMET00053 | |
| 0.03 | 0.069 | 0.081 | Ornithine carbamoyltransferase inhibitor | 0.077 0.023 DBMET00053 0.081 0.021 DBMET00482 | DBMET00482 | |
| 0.038 | 0.077 | 0.05 | Cytokine production stimulant | 0.05 0.029 DBMET00053 | DBMET00053 | |
| 0.095 | 0.135 | 0.252 | Peroxidase inhibitor | 0.252 0.047 DBMET00053 0.121 0.099 DBMET00482 | DBMET00053 | |
| 0.05 | 0.09 | 0.067 | Interferon inducer | 0.067 0.039 DBMET00053 0.065 0.043 DBMET00482 | DBMET00053 | |
| 0.017 | 0.057 | 0.028 | Prostaglandin D2 agonist | 0.028 0.025 DBMET00482 | DBMET00482 | |
| 0.084 | 0.125 | 0.101 | TRPA1 agonist | 0.101 0.086 DBMET00053 | DBMET00053 | |
| 0.061 | 0.102 | 0.072 | Estrogen receptor alpha antagonist | 0.072 0.064 DBMET00052 0.071 0.066 DBMET00482 | DBMET00052 | |
| 0.053 | 0.096 | 0.083 | Glutamate (mGluR6) antagonist | 0.083 0.021 DBMET00053 0.075 0.03 DBMET00482 | DBMET00053 | |
| 0.067 | 0.109 | 0.098 | Triose-phosphate isomerase inhibitor | 0.09 0.059 DBMET00053 0.098 0.05 DBMET00482 | DBMET00482 | |
| 0.04 | 0.083 | 0.05 | Glucosylceramidase inhibitor | 0.05 0.047 DBMET00052 | DBMET00052 | |
| 0.039 | 0.082 | 0.093 | NMDA 2C receptor antagonist | 0.093 0.018 DBMET00053 | DBMET00053 | |
| 0.047 | 0.092 | 0.176 | Porphobilinogen synthase inhibitor | 0.176 0.016 DBMET00053 0.092 0.04 DBMET00482 | DBMET00053 | |
| 0.02 | 0.066 | 0.026 | Hedgehog signaling activator | 0.026 0.025 DBMET00482 | DBMET00482 | |
| 0.011 | 0.057 | 0.023 | Methionyl aminopeptidase 2 inhibitor | 0.023 0.021 DBMET00053 | DBMET00053 | |
| 0.04 | 0.087 | 0.087 | Phosphofructokinase-1 inhibitor | 0.064 0.053 DBMET00053 0.087 0.037 DBMET00482 | DBMET00482 | |
| 0.07 | 0.117 | 0.152 | Carbonic anhydrase III inhibitor | 0.138 0.033 DBMET00053 0.152 0.028 DBMET00482 | DBMET00482 | |
| 0.222 | 0.269 | 0.33 | 5 Hydroxytryptamine release inhibitor | 0.33 0.133 DBMET00053 0.249 0.229 DBMET00482 | DBMET00053 | |
| 0.027 | 0.075 | 0.048 | Mannosidase inhibitor | 0.048 0.027 DBMET00482 | DBMET00482 | |
| 0.012 | 0.06 | 0.025 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET00052 0.025 0.005 DBMET00482 | DBMET00482 | |
| 0.036 | 0.086 | 0.091 | Carbamoyl phosphate synthetase inhibitor | 0.073 0.032 DBMET00053 0.091 0.024 DBMET00482 | DBMET00482 | |
| 0.047 | 0.097 | 0.144 | Glutamate decarboxylase inhibitor | 0.144 0.014 DBMET00053 0.113 0.023 DBMET00482 | DBMET00053 | |
| 0.11 | 0.161 | 0.136 | Interferon gamma antagonist | 0.125 0.121 DBMET00052 0.136 0.099 DBMET00482 | DBMET00482 | |
| 0.05 | 0.1 | 0.068 | Glutamate (mGluR7) antagonist | 0.068 0.047 DBMET00053 | DBMET00053 | |
| 0.137 | 0.189 | 0.176 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.165 0.117 DBMET00053 0.176 0.098 DBMET00482 | DBMET00482 | |
| 0.02 | 0.073 | 0.035 | Dipeptidyl peptidase II inhibitor | 0.035 0.019 DBMET00053 | DBMET00053 | |
| 0.062 | 0.115 | 0.139 | HIV-1 integrase (Overall Integration) inhibitor | 0.139 0.029 DBMET00053 0.104 0.051 DBMET00482 | DBMET00053 | |
| 0.026 | 0.08 | 0.049 | Neurokinin 2 agonist | 0.049 0.02 DBMET00053 | DBMET00053 | |
| 0.006 | 0.061 | 0.015 | Carbonic anhydrase VIII inhibitor | 0.015 0.013 DBMET00053 | DBMET00053 | |
| 0.006 | 0.061 | 0.015 | Carbonic anhydrase X inhibitor | 0.015 0.013 DBMET00053 | DBMET00053 | |
| 0.027 | 0.082 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.034 DBMET00053 | DBMET00053 | |
| 0.034 | 0.09 | 0.049 | Lysine-specific demethylase 1A inhibitor | 0.049 0.047 DBMET00053 | DBMET00053 | |
| 0.038 | 0.095 | 0.085 | NMDA 2 receptor antagonist | 0.074 0.047 DBMET00053 0.085 0.041 DBMET00482 | DBMET00482 | |
| 0.032 | 0.09 | 0.046 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.036 DBMET00482 | DBMET00482 | |
| 0.021 | 0.08 | 0.03 | Carboxypeptidase B inhibitor | 0.03 0.029 DBMET00053 | DBMET00053 | |
| 0.068 | 0.127 | 0.088 | Protein kinase C zeta inhibitor | 0.088 0.069 DBMET00053 | DBMET00053 | |
| 0.089 | 0.148 | 0.136 | Transcription factor STAT6 inhibitor | 0.136 0.036 DBMET00053 | DBMET00053 | |
| 0.052 | 0.112 | 0.171 | Glycine receptor agonist | 0.135 0.009 DBMET00053 0.171 0.005 DBMET00482 | DBMET00482 | |
| 0.042 | 0.101 | 0.057 | 5 Hydroxytryptamine 3 agonist | 0.057 0.055 DBMET00053 | DBMET00053 | |
| 0.055 | 0.115 | 0.075 | I kappa B kinase inhibitor | 0.075 0.069 DBMET00053 | DBMET00053 | |
| 0.011 | 0.071 | 0.03 | AMPA 2 receptor antagonist | 0.03 0.02 DBMET00053 | DBMET00053 | |
| 0.018 | 0.078 | 0.024 | Complement factor 1s inhibitor | 0.024 0.022 DBMET00053 | DBMET00053 | |
| 0.15 | 0.211 | 0.166 | Nitric-oxide synthase stimulant | 0.166 0.164 DBMET00053 | DBMET00053 | |
| 0.023 | 0.084 | 0.043 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET00052 0.034 0.029 DBMET00053 0.043 0.018 DBMET00482 | DBMET00482 | |
| 0.134 | 0.197 | 0.199 | Cardiotonic | 0.199 0.12 DBMET00052 | DBMET00052 | |
| 0.077 | 0.141 | 0.134 | Bone formation stimulant | 0.134 0.072 DBMET00053 | DBMET00053 | |
| 0.067 | 0.131 | 0.098 | DNA intercalator | 0.098 0.076 DBMET00052 | DBMET00052 | |
| 0.032 | 0.097 | 0.054 | NMDA receptor glycine site agonist | 0.054 0.053 DBMET00053 | DBMET00053 | |
| 0.016 | 0.081 | 0.035 | Kainate receptor antagonist | 0.035 0.034 DBMET00053 | DBMET00053 | |
| 0.014 | 0.08 | 0.027 | Complement C5a chemotactic receptor antagonist | 0.027 0.024 DBMET00053 | DBMET00053 | |
| 0.1 | 0.167 | 0.124 | Thiol protease inhibitor | 0.124 0.108 DBMET00053 | DBMET00053 | |
| 0.066 | 0.134 | 0.081 | Hematopoietic | 0.081 0.069 DBMET00053 | DBMET00053 | |
| 0.053 | 0.122 | 0.085 | Keratolytic | 0.083 0.044 DBMET00053 0.085 0.043 DBMET00482 | DBMET00482 | |
| 0.031 | 0.105 | 0.072 | Biliverdin reductase inhibitor | 0.069 0.033 DBMET00053 0.072 0.031 DBMET00482 | DBMET00482 | |
| 0.035 | 0.109 | 0.056 | Botulinum neurotoxin type A inhibitor | 0.056 0.044 DBMET00053 | DBMET00053 | |
| 0.028 | 0.104 | 0.062 | GABA B receptor antagonist | 0.062 0.011 DBMET00053 0.045 0.025 DBMET00482 | DBMET00053 | |
| 0.028 | 0.104 | 0.148 | Alcohol oxidase inhibitor | 0.114 0.015 DBMET00053 0.148 0.01 DBMET00482 | DBMET00482 | |
| 0.021 | 0.097 | 0.049 | Adenosine deaminase inhibitor | 0.041 0.04 DBMET00053 0.049 0.031 DBMET00482 | DBMET00482 | |
| 0.038 | 0.114 | 0.194 | Histidine decarboxylase inhibitor | 0.129 0.023 DBMET00053 0.194 0.014 DBMET00482 | DBMET00482 | |
| 0.116 | 0.193 | 0.255 | Immunostimulant | 0.159 0.147 DBMET00052 0.198 0.121 DBMET00053 0.255 0.094 DBMET00482 | DBMET00482 | |
| 0.025 | 0.103 | 0.044 | GHS receptor agonist | 0.044 0.028 DBMET00053 | DBMET00053 | |
| 0.06 | 0.139 | 0.097 | NADH dehydrogenase inhibitor | 0.084 0.066 DBMET00053 0.097 0.047 DBMET00482 | DBMET00482 | |
| 0.011 | 0.091 | 0.033 | Prostaglandin agonist | 0.033 0.018 DBMET00482 | DBMET00482 | |
| 0.023 | 0.108 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.029 DBMET00053 | DBMET00053 | |
| 0.058 | 0.145 | 0.094 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.061 DBMET00053 0.092 0.063 DBMET00482 | DBMET00053 | |
| 0.013 | 0.102 | 0.031 | Fumarate hydratase inhibitor | 0.031 0.028 DBMET00482 | DBMET00482 | |
| 0.022 | 0.112 | 0.045 | Carbonic anhydrase XIV inhibitor | 0.045 0.039 DBMET00053 | DBMET00053 | |
| 0.054 | 0.148 | 0.093 | GABA B receptor agonist | 0.093 0.023 DBMET00053 0.078 0.046 DBMET00482 | DBMET00053 | |
| 0.103 | 0.2 | 0.156 | Insulin sensitizer | 0.156 0.125 DBMET00053 | DBMET00053 | |
| 0.056 | 0.154 | 0.091 | UDP-glucose 4-epimerase inhibitor | 0.091 0.072 DBMET00482 | DBMET00482 | |
| 0.028 | 0.128 | 0.055 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.055 0.04 DBMET00482 | DBMET00482 | |
| 0.032 | 0.133 | 0.063 | Carbonic anhydrase VA inhibitor | 0.063 0.056 DBMET00053 | DBMET00053 | |
| 0.017 | 0.118 | 0.04 | Guanylate cyclase inhibitor | 0.04 0.034 DBMET00053 | DBMET00053 | |
| 0.043 | 0.145 | 0.14 | Somatostatin 1 agonist | 0.14 0.016 DBMET00053 0.117 0.025 DBMET00482 | DBMET00053 | |
| 0.027 | 0.13 | 0.043 | Glutamate (mGluR group III) antagonist | 0.043 0.033 DBMET00053 | DBMET00053 | |
| 0.016 | 0.124 | 0.055 | Carbonic anhydrase VB inhibitor | 0.055 0.039 DBMET00053 | DBMET00053 | |
| 0.026 | 0.139 | 0.041 | Glutamate (mGluR4) antagonist | 0.041 0.036 DBMET00053 | DBMET00053 | |
| 0.015 | 0.132 | 0.041 | Phosphorylase inhibitor | 0.041 0.036 DBMET00052 | DBMET00052 | |
| 0.017 | 0.136 | 0.056 | Growth hormone release inhibitor | 0.056 0.018 DBMET00053 0.039 0.032 DBMET00482 | DBMET00053 | |
| 0.01 | 0.131 | 0.037 | Phosphoglycerate kinase inhibitor | 0.037 0.022 DBMET00482 | DBMET00482 | |
| 0.181 | 0.305 | 0.417 | Cyclophilin D inhibitor | 0.358 0.116 DBMET00052 0.246 0.217 DBMET00053 0.417 0.082 DBMET00482 | DBMET00482 | |
| 0.066 | 0.191 | 0.123 | Cyclooxygenase 3 inhibitor | 0.11 0.09 DBMET00053 0.123 0.075 DBMET00482 | DBMET00482 | |
| 0.011 | 0.137 | 0.041 | Vascular adhesion protein 1 inhibitor | 0.041 0.024 DBMET00053 | DBMET00053 | |
| 0.041 | 0.169 | 0.062 | Trypsin inhibitor | 0.062 0.044 DBMET00053 | DBMET00053 | |
| 0.057 | 0.19 | 0.093 | Mucolytic | 0.093 0.088 DBMET00482 | DBMET00482 | |
| 0.085 | 0.226 | 0.232 | Hepatoprotectant | 0.216 0.056 DBMET00052 0.232 0.049 DBMET00482 | DBMET00482 | |
| 0.142 | 0.285 | 0.248 | Sodium/bile acid cotransporter inhibitor | 0.248 0.13 DBMET00052 0.202 0.185 DBMET00482 | DBMET00052 | |
| 0.009 | 0.152 | 0.024 | Somatostatin 4 antagonist | 0.024 0.016 DBMET00053 | DBMET00053 | |
| 0.01 | 0.161 | 0.033 | HMG CoA reductase inhibitor | 0.033 0.026 DBMET00482 | DBMET00482 | |
| 0.014 | 0.166 | 0.035 | Glutamate (mGluR3) antagonist | 0.035 0.028 DBMET00053 | DBMET00053 | |
| 0.052 | 0.205 | 0.192 | Amylase inhibitor | 0.123 0.079 DBMET00053 0.192 0.047 DBMET00482 | DBMET00482 | |
| 0.148 | 0.302 | 0.435 | Interleukin 2 agonist | 0.32 0.061 DBMET00052 0.347 0.047 DBMET00053 0.435 0.019 DBMET00482 | DBMET00482 | |
| 0.141 | 0.295 | 0.272 | Toll-Like receptor 7 agonist | 0.272 0.129 DBMET00052 0.262 0.137 DBMET00482 | DBMET00052 | |
| 0.077 | 0.232 | 0.154 | Sphingosine 1-phosphate receptor 2 agonist | 0.15 0.025 DBMET00052 0.154 0.024 DBMET00482 | DBMET00482 | |
| 0.139 | 0.298 | 0.279 | Toll-Like receptor agonist | 0.268 0.133 DBMET00052 0.279 0.125 DBMET00482 | DBMET00482 | |
| 0.081 | 0.243 | 0.129 | Hemostatic | 0.129 0.097 DBMET00053 | DBMET00053 | |
| 0.043 | 0.205 | 0.081 | ATPase (Vacuolar H+) inhibitor | 0.081 0.075 DBMET00052 | DBMET00052 | |
| 0.006 | 0.169 | 0.041 | Somatostatin 2 antagonist | 0.041 0.017 DBMET00053 | DBMET00053 | |
| 0.095 | 0.264 | 0.267 | Antioxidant | 0.231 0.095 DBMET00052 0.267 0.075 DBMET00482 | DBMET00482 | |
| 0.01 | 0.188 | 0.041 | Opioid mu receptor agonist | 0.041 0.039 DBMET00482 | DBMET00482 | |
| 0.113 | 0.293 | 0.185 | Transcription factor STAT3 inhibitor | 0.185 0.157 DBMET00053 | DBMET00053 | |
| 0.075 | 0.26 | 0.212 | Nitric oxide antagonist | 0.18 0.076 DBMET00052 0.212 0.063 DBMET00482 | DBMET00482 | |
| 0.009 | 0.198 | 0.03 | Plasmepsin I inhibitor | 0.03 0.021 DBMET00482 | DBMET00482 | |
| 0.127 | 0.335 | 0.309 | Apoptosis antagonist | 0.254 0.124 DBMET00052 0.309 0.08 DBMET00482 | DBMET00482 | |
| 0.038 | 0.249 | 0.092 | Aminoacyl-tRNA synthetase inhibitor | 0.08 0.077 DBMET00053 0.092 0.055 DBMET00482 | DBMET00482 | |
| 0.029 | 0.241 | 0.119 | Protein kinase B gamma inhibitor | 0.119 0.025 DBMET00053 | DBMET00053 | |
| 0.035 | 0.253 | 0.055 | Lipocortins synthesis agonist | 0.055 0.05 DBMET00482 | DBMET00482 | |
| 0.055 | 0.273 | 0.126 | Anticoagulant | 0.126 0.105 DBMET00053 | DBMET00053 | |
| 0.01 | 0.232 | 0.058 | Somatostatin 1 antagonist | 0.058 0.016 DBMET00053 0.039 0.027 DBMET00482 | DBMET00053 | |
| 0.052 | 0.275 | 0.213 | Angiogenesis stimulant | 0.188 0.101 DBMET00053 0.213 0.088 DBMET00482 | DBMET00482 | |
| 0.105 | 0.328 | 0.336 | Immunosuppressant | 0.297 0.117 DBMET00052 0.336 0.094 DBMET00482 | DBMET00482 | |
| 0.142 | 0.37 | 0.19 | MAP kinase kinase 3 inhibitor | 0.19 0.153 DBMET00053 | DBMET00053 | |
| 0.113 | 0.37 | 0.332 | Antibacterial | 0.221 0.206 DBMET00052 0.332 0.113 DBMET00482 | DBMET00482 | |
| 0.003 | 0.274 | 0.026 | RNA-directed RNA polymerase stimulant | 0.026 0.023 DBMET00482 | DBMET00482 | |
| 0.084 | 0.368 | 0.188 | Transcription factor STAT inhibitor | 0.188 0.156 DBMET00053 | DBMET00053 | |
| 0.051 | 0.337 | 0.257 | Interleukin antagonist | 0.257 0.059 DBMET00053 0.186 0.092 DBMET00482 | DBMET00053 | |
| 0.04 | 0.334 | 0.117 | Toll-Like receptor 4 antagonist | 0.117 0.047 DBMET00482 | DBMET00482 | |
| 0.032 | 0.339 | 0.198 | Thrombolytic | 0.188 0.058 DBMET00053 0.198 0.053 DBMET00482 | DBMET00482 | |
| 0.008 | 0.323 | 0.029 | Somatostatin agonist | 0.029 0.024 DBMET00053 | DBMET00053 | |
| 0.011 | 0.328 | 0.057 | Somatostatin 5 agonist | 0.057 0.01 DBMET00053 0.04 0.019 DBMET00482 | DBMET00053 | |
| 0.007 | 0.331 | 0.11 | Antineoplastic antibiotic | 0.086 0.053 DBMET00052 0.11 0.042 DBMET00482 | DBMET00482 | |
| 0.009 | 0.387 | 0.055 | NMDA 2B receptor antagonist | 0.055 0.036 DBMET00482 | DBMET00482 | |
| 0.031 | 0.425 | 0.126 | DNA polymerase I inhibitor | 0.113 0.074 DBMET00052 0.126 0.064 DBMET00482 | DBMET00482 | |
| 0.045 | 0.444 | 0.166 | Interleukin 6 antagonist | 0.166 0.068 DBMET00482 | DBMET00482 | |
| 0.081 | 0.501 | 0.288 | Caspase 3 stimulant | 0.279 0.09 DBMET00052 0.288 0.085 DBMET00482 | DBMET00482 | |
| 0.031 | 0.459 | 0.165 | Hypolipemic | 0.164 0.123 DBMET00052 0.165 0.123 DBMET00482 | DBMET00482 | |
| 0.004 | 0.432 | 0.041 | Somatostatin 5 antagonist | 0.041 0.018 DBMET00053 | DBMET00053 | |
| 0.054 | 0.578 | 0.183 | Death-associated protein kinase 2 inhibitor | 0.183 0.051 DBMET00053 0.154 0.098 DBMET00482 | DBMET00053 | |
| 0.023 | 0.771 | 0.257 | Immunomodulator | 0.257 0.11 DBMET00482 | DBMET00482 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |